Analyst Discounts Chances For OHR Pharmaceutical Eye Drug

OHR Pharmaceutical Inc (NASDAQ: OHRP ) shares plunged Friday after its lead product for eye disease failed to meet the end-point of a mid-stage trial. The company changed hands recently at $2.86, down ...

Source: http://finance.yahoo.com/news/analyst-discounts-chances-ohr-pharmaceutical-180219032.html

shop the bay coupons printable coupons restaurant printable coupons websites printable coupons sites